Illustration: Natalie Peeples/Axios
General Proximity raised an $8 million seed to grow its drug discovery platform, CEO Armand Cognetta tells Axios exclusively.
Why it matters: The company's approach shows promise in identifying drug candidates for difficult-to-treat conditions like dementia.
